Daniel E Michalik1, Bradley W Taylor2, Julie A Panepinto3. 1. Medical College of Wisconsin/The Children's Research Institute of the Children's Hospital of Wisconsin, Pediatric Hematology/Oncology/Bone Marrow Transplant, Milwaukee. Electronic address: dmichalik@mcw.edu. 2. Clinical and Translational Science Institute of Southeastern Wisconsin, Milwaukee. 3. Medical College of Wisconsin/The Children's Research Institute of the Children's Hospital of Wisconsin, Pediatric Hematology/Oncology/Bone Marrow Transplant, Milwaukee.
Abstract
OBJECTIVE: To develop and validate a computable phenotype algorithm for identifying patient populations with sickle cell disease. METHODS: In this retrospective study we used electronic health record data from the Children's Hospital of Wisconsin to develop a computable phenotype algorithm for sickle cell disease. The algorithm was on the basis of the International Classification of Diseases, Ninth Revision codes, number of visits, and hospital admissions for sickle cell disease. Using Informatics for Integrating Biology and the Bedside queries, the algorithm was refined in an iterative process. The final algorithm was verified using manual medical records review and by comparison with a gold standard set of confirmed sickle cell cases. The algorithm was then validated at Froedtert Hospital, a neighboring health system for adults. RESULTS: From the Children's Hospital of Wisconsin, our computable phenotype algorithm identified patients with confirmed sickle cell disease with a positive predictive value of 99.4% and a sensitivity of 99.4%. Additionally, using data from Froedtert, the computable phenotype algorithm identified patients with confirmed sickle cell disease with a positive predictive value of 95.8% and a sensitivity of 98.3%. CONCLUSIONS: The computable phenotype algorithm developed in this study had a high sensitivity and positive predictive value when identifying patients with sickle cell disease in the electronic health records of the Children's Hospital of Wisconsin and Froedtert, a neighboring health system for adults. Our algorithm allows us to harness data provided by the electronic health record to rapidly and accurately identify patient with sickle cell disease and is a rich resource for future clinical trials.
OBJECTIVE: To develop and validate a computable phenotype algorithm for identifying patient populations with sickle cell disease. METHODS: In this retrospective study we used electronic health record data from the Children's Hospital of Wisconsin to develop a computable phenotype algorithm for sickle cell disease. The algorithm was on the basis of the International Classification of Diseases, Ninth Revision codes, number of visits, and hospital admissions for sickle cell disease. Using Informatics for Integrating Biology and the Bedside queries, the algorithm was refined in an iterative process. The final algorithm was verified using manual medical records review and by comparison with a gold standard set of confirmed sickle cell cases. The algorithm was then validated at Froedtert Hospital, a neighboring health system for adults. RESULTS: From the Children's Hospital of Wisconsin, our computable phenotype algorithm identified patients with confirmed sickle cell disease with a positive predictive value of 99.4% and a sensitivity of 99.4%. Additionally, using data from Froedtert, the computable phenotype algorithm identified patients with confirmed sickle cell disease with a positive predictive value of 95.8% and a sensitivity of 98.3%. CONCLUSIONS: The computable phenotype algorithm developed in this study had a high sensitivity and positive predictive value when identifying patients with sickle cell disease in the electronic health records of the Children's Hospital of Wisconsin and Froedtert, a neighboring health system for adults. Our algorithm allows us to harness data provided by the electronic health record to rapidly and accurately identify patient with sickle cell disease and is a rich resource for future clinical trials.
Authors: Andrew Srisuwananukorn; Rasha Raslan; Xu Zhang; Binal N Shah; Jin Han; Michel Gowhari; Robert E Molokie; Victor R Gordeuk; Santosh L Saraf Journal: Blood Adv Date: 2020-05-12
Authors: Jin Han; Jifang Zhou; Santosh L Saraf; Victor R Gordeuk; Gregory S Calip Journal: Pharmacoepidemiol Drug Saf Date: 2017-08-16 Impact factor: 2.890
Authors: Sarah L Reeves; Brian Madden; Meng Wu; Lauren S Miller; David Anders; Michele Caggana; Lindsay W Cogan; Mary Kleyn; Isabel Hurden; Gary L Freed; Kevin J Dombkowski Journal: Health Serv Res Date: 2020-01-09 Impact factor: 3.402
Authors: Jin Han; Jifang Zhou; Vinod Kondragunta; Xu Zhang; Robert E Molokie; Michel Gowhari; Johara Hassan; Shivi Jain; Gregory S Calip; Victor R Gordeuk; Santosh L Saraf Journal: Br J Haematol Date: 2017-07-27 Impact factor: 6.998
Authors: Benjamin S Glicksberg; Riccardo Miotto; Kipp W Johnson; Khader Shameer; Li Li; Rong Chen; Joel T Dudley Journal: Pac Symp Biocomput Date: 2018
Authors: Tellen D Bennett; Tiffany J Callahan; James A Feinstein; Debashis Ghosh; Saquib A Lakhani; Michael C Spaeder; Stanley J Szefler; Michael G Kahn Journal: J Pediatr Date: 2019-01-25 Impact factor: 4.406